Lv1
26 积分 2025-02-21 加入
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
55分钟前
待确认
Recent advances in carrier-free natural small molecule self-assembly for drug delivery
3个月前
已完结
Long-Acting and Stapled GLP-1R/GIPR/GCGR Triple Agonist for the Treatment of Obesity and Atherosclerosis
4个月前
已完结
Agonism and Biased Signaling
5个月前
已完结
Prostanoid signal transduction and gene expression in the endothelium: role in Cardiovascular Diseases
7个月前
已完结
Synthesis and evaluation of Diphenylpyrazine Cyclic Amine Derivatives as IP Receptor Agonists
7个月前
已完结
Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension
7个月前
已完结
Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension
7个月前
已完结
Selexipag: A Review in Pulmonary Arterial Hypertension
7个月前
已完结
Pyruvate kinase modulators as a therapy target: an updated patent review 2018–2023
7个月前
已完结
皖公网安备34019202002308
